Pharmaceuticals Benefits Scheme in Australia: Issues and Betterment Procedures

PBS

Executive Summary
The study has highlighted various discussions regarding Pharmaceuticals benefits scheme. This
scheme is important to minimize the cause of medicines and which can be beneficial for the
common Australians to decrease the medical costs. The Australian government has enforced this
issue under the section National health Act (1953). The Australian government uses to invest
21% of their total medical allotment on pharmaceutical Benefit Scheme. The issues highlighted
are the unethical advantage issue, delay issue, and methodological issue. The issues must be
decreased with an effective initiative from the Australian government and high-level rigor.
1 | P a g e

Table of Contents
Executive Summary.....................................................................................................................................1
Introduction.................................................................................................................................................3
General discussion of issue..........................................................................................................................3
Issues explored............................................................................................................................................5
Conclusions.................................................................................................................................................6
References...................................................................................................................................................8
2 | P a g e